Physician profile
Jonathan C Aki
NPI 1629284674
$627.26
in general payments reported to CMS, 2019-2025
10 companies · $242 in 2025
The $242 reported for 2025 was more than what 86% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.49 · 2022: $54.38 · 2023: $162 · 2024: $143 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $291.85 | 2022-2025 | Dalvance |
| Melinta Therapeutics, LLC | $79.56 | 2023 | Kimyrsa |
| Dynasplint Systems INC. | $44.74 | 2025 | Dynasplint |
| Bioventus LLC | $39.75 | 2024-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $36.86 | 2022-2023 | Nuzyra |
| Horizon Therapeutics Plc | $35.36 | 2023 | Krystexxa |
| Mimedx Group, INC. | $33.49 | 2025 | |
| Averitas Pharma INC. | $26.44 | 2024 | Qutenza |
| Boston Scientific Corporation | $25.49 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.72 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Aki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.